Top Industry News

Apollo, a private equity firm, has announced a EUR 3-billion ($3.4 billion) equity capital investment in Bayer’s long-acting reversible contraceptives (LARC) business.   Under the agreement, Apollo-managed funds and affiliates will obtain a minority, non-controlling stake in a…

The US Food and Drug Administration has issued a proposed rule, which if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a single establishment using a “hub-and-spoke” model. The…

Eli Lilly and Company has agreed to acquire AtaiBeckley, a New York-based clinical-stage bio/pharmaceutical company developing therapeutics for mental healh conditions, in a $3.8-billion deal ($2.8 billion upfront and $1 billion in contingent value right [CVR]).    AtaiBeckley is advancing a pipeline of rapid-acting psychedelic-based neuroplastogens. The company’s lead…

The latest from CDMOs, CMOs, and suppliers featuring Bora Pharmaceuticals, Rottendorf Pharma, MilliporeSigma, AGC Biologics, Pyramid Pharma Services, Kindeva, Evonik, Brenntag, evitria, Syngene, and Cytovance.   Chemicals/Chemical API Manufacturing * Evonik Names Brenntag as European Distributor for Pharma Amino Acids Biologics Manufacturing * MilliporeSigma Opens…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Dr. Reddy’s Laboratories, Servier, and AstraZeneca. Highlights below.   For the latest news roundup on small and Emerging Pharma companies, see Biotech…

The latest from small and Emerging Pharma companies featuring Innovent Biologics, Spero Therapeutics, Erasca, Chai Discovery, AdvanCell, Attovia Therapeutics, Avere Therapeutics, NextCure, Celcuity, Orca Bio, Summit Therapeutics and Biossi.  For news…

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals, a San Diego, California-based bio/pharmaceutical company focused on endocrine diseases, for $10 billion.  Crinetics’ marketed medicine is Palsonify (paltusotine), a once-daily oral therapy for adults with acromegaly, a rare condition caused by a…

Novartis has agreed to acquire Myricx Bio, a privately held London-based bio/pharmaceutical company developing antibody-drug conjugates (ADCs), in a deal worth up to $1.5 billion ($1.1 billion upfront and $400 million in milestone payments).   Myricx is developing ADCs using N-myristoyltransferase inhibitor (NMTi)…

Evonik has announced a $100-million investment to strengthen its active pharmaceutial ingredient manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. Over the next five years, Evonik will invest $100 million to…

The latest from CDMOs, CMOs, and suppliers featuring Lonza, Olon, Bora Pharmaceuticals, Codis, Icosagen, Mikart, Thermo Fisher, Gattefosse, Just Evotec Biologics, Rentschler Biopharma and Nona Biosciences.   Chemicals/Chemical API Manufacturing * Lonza Expands HPAPI Mfg Facility* Olon Completes Expansion…